HSR21-063: Treatment Patterns Among Patients With EGFR Mutated Metastatic NSCLC Who Have Discontinued EGFR-TKI and Platinum-Based Chemotherapy Regimens

Authors:
Elizabeth Marrett Daiichi Sankyo, Inc., Basking Ridge, NJ

Search for other papers by Elizabeth Marrett in
Current site
Google Scholar
PubMed Close
 MPH
,
Winghan Jacqueline Kwong Daiichi Sankyo, Inc., Basking Ridge, NJ

Search for other papers by Winghan Jacqueline Kwong in
Current site
Google Scholar
PubMed Close
 PharmD, PhD
,
Jipan Xie Analysis Group, Los Angeles, CA

Search for other papers by Jipan Xie in
Current site
Google Scholar
PubMed Close
 MD, PhD
,
Ameur Manceur Analysis Group, Montreal, Canada

Search for other papers by Ameur Manceur in
Current site
Google Scholar
PubMed Close
 PhD
,
Selvam Sendhil Analysis Group, Los Angeles, CA

Search for other papers by Selvam Sendhil in
Current site
Google Scholar
PubMed Close
 BA
,
Eric Wu Analysis Group, Boston MA

Search for other papers by Eric Wu in
Current site
Google Scholar
PubMed Close
 PhD
, and
Raluca Ionescu-Ittu Analysis Group, Montreal, Canada

Search for other papers by Raluca Ionescu-Ittu in
Current site
Google Scholar
PubMed Close
 PhD
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7710
Restricted access

Corresponding Author: Elizabeth Marrett, MPH
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1381 496 105
PDF Downloads 365 0 0
EPUB Downloads 0 0 0